Study links protein increases to cognitive improvement in Alzheimer’s

A study published in the journal Brain shows that increases in protein levels with new Alzheimer’s drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

AD/PD 2024: BioVie’s novel NE3107 shows promise but confirmatory trial needed – Pharmaceutical Technology

Share this article On 8 March, at the AD/PD 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, during a symposium titled “Therapeutic Intervention in AD

March 11, 2024

Pioneering cell-based treatment for melanoma offered at Siteman Cancer Center

Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer

February 21, 2024

FDA sets December approval decision for first CRISPR therapy, with 94% of patients free of sickle cell crises

Nearly 11 years ago, scientists programmed a pair of molecular scissors to make precise cuts in DNA. That first test tube experiment of CRISPR gene

June 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.